Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
LG Life Sciences logo — company profile

LG Life Sciences

Founded 2002 374 employees Biotechnology, Pharmaceutical

General Information

Company Name LG Life Sciences
Founded Year 2002
Employees 374
Industries Biotechnology, Pharmaceutical
Social

Get notified when LG Life Sciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About LG Life Sciences

LG Life Sciences, established in 2002, has been a pioneer in genetic engineering, focusing on pharmaceuticals, animal health, and specialty chemicals. The company has achieved significant milestones in the development and commercialization of various pharmaceuticals, including interferon, hepatitis B vaccine, human growth hormone, and degenerative arthritis treatment, among others. Notably, their next-generation quinolone antibiotic, FACTIVE®, was approved by the FDA in 2003, marking a significant achievement. With a vision to become a "top-tier life sciences company with world-class new drugs," LG Life Sciences is strategically expanding its alliances and capabilities to accelerate the development of new medicines. The company is also focusing its marketing competencies on advanced markets, reflecting its commitment to growth and innovation. As LG Life Sciences continues to lead in the biotechnology and pharmaceutical industries, it remains focused on knowledge-intensive, value-added areas, ensuring its position as a leader in the future of life sciences and biotechnology.

No funding data available for LG Life Sciences yet.

Get notified when LG Life Sciences raises funding

LG Life Sciences Alternatives & Competitors

LG Life Sciences vs
Asieris Pharmaceuticals
Asieris Pharmaceuticals United States

We strive for healthy and dignified lives!

Series D
60 employees
Biotechnology, Health Care
LG Life Sciences vs
Athersys
Athersys United States

Committed to developing therapies to extend and enhance the quality of life.

Post Ipo Equity
37 employees
Biopharma, Biotechnology
LG Life Sciences vs
Bioneer
Bioneer Korea South

Since its founding in 1992 Bioneer Corporation has established market leadership in Korea for most o...

109 employees
Biotechnology, Health Care

FAQ About LG Life Sciences

LG Life Sciences began research in genetic engineering in 1981 and has invested steadily in the life sciences ever since. This effort has already resulted in world-class technology and product capabilities. The company has focused R&D resources and know-how on three areas-pharmaceuticals, animal hea...
LG Life Sciences was founded in 2002.
LG Life Sciences operates in the following industries: Biotechnology, Pharmaceutical.
LG Life Sciences has approximately 374 employees.
Top alternatives and competitors to LG Life Sciences include Asieris Pharmaceuticals, Athersys, Bioneer, Trusted Health Advisors, Alteogen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LG Life Sciences and Asieris Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors LG Life Sciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy